Actively Recruiting
Open-Label Extension Protocol to SNK01-AD01 Study
Led by NKGen Biotech, Inc. · Updated on 2025-11-13
30
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Open-Label Extension Protocol to SNK01-AD01 Study
CONDITIONS
Official Title
Open-Label Extension Protocol to SNK01-AD01 Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing and able to give informed consent in writing or have a legally authorized representative who can
- Have a reliable study partner/caregiver in close contact and able to assist with functional assessments
- Previously completed participation in the SNK01-AD01 study
You will not qualify if you...
- Any participant whose safety is considered at risk by the investigator due to the trial intervention
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Behavioral Research Specialists, LLC
Glendale, California, United States, 91206
Actively Recruiting
Research Team
S
Study Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here